MENU
+Compare
EDTXF
Stock ticker: OTC
AS OF
Jan 16 closing price
Price
$0.35
Change
-$0.03 (-7.89%)
Capitalization
68.29M

EDTXF Spectral Medical Inc. Forecast, Technical & Fundamental Analysis

EDTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for EDTXF with price predictions
Jan 08, 2025

EDTXF sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for EDTXF moved below the 200-day moving average on December 31, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

EDTXF broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EDTXF entered a downward trend on January 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 31, 2024. You may want to consider a long position or call options on EDTXF as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EDTXF just turned positive on December 26, 2024. Looking at past instances where EDTXF's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

EDTXF moved above its 50-day moving average on January 06, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where EDTXF advanced for three days, in of 142 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EDTXF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (52.083) is normal, around the industry mean (23.424). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (50.505) is also within normal values, averaging (41.167).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDTXF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
EDTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
135 - 2 The West Mall
Phone
+1 416 626-3233
Employees
32
Web
https://www.spectraldx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
FTM.X0.697689N/A
N/A
Fantom cryptocurrency
MFT.X0.005341-0.000399
-6.95%
Mainframe cryptocurrency
LINA.X0.004082-0.000426
-9.45%
Linear Finance cryptocurrency
TRU.X0.071155-0.007744
-9.81%
TrueFi cryptocurrency
ELF.X0.378207-0.054670
-12.63%
aelf cryptocurrency

EDTXF and Stocks

Correlation & Price change

A.I.dvisor tells us that EDTXF and ASAPF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDTXF and ASAPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDTXF
1D Price
Change %
EDTXF100%
N/A
ASAPF - EDTXF
22%
Poorly correlated
N/A
KSRBF - EDTXF
21%
Poorly correlated
N/A
TDSGF - EDTXF
20%
Poorly correlated
-8.67%
FSPKF - EDTXF
3%
Poorly correlated
N/A
DSRLF - EDTXF
3%
Poorly correlated
N/A
More